Videos

Elise
Pattyn
Arteveldehogeschool

Returning to work after a long-term illness 🎗 🏥 💼

In Belgium, every year more than 25,000 people return to work after cancer treatment. Yet there are many employers who do not know how to react in such a situation. Elise Pattyn (Arteveldehogeschool) and her colleagues are working on tools to make the return to work smoother.
Ben
Rombaut
FWO
UHasselt

In search of the cause of Alzheimer's

In patients with Alzheimer's, microglia, the immune cells that protect our brains, suddenly start damaging the brain themselves by eating synapses. Ben Rombaut is trying to find out why this happens. In this way, he wants to help ensure that in our old age we can all stay on our toes.
James
Wambua
UHasselt

The dilemma of Varicella vaccination in Belgium

People who had chickenpox as a child seem to be better protected against herpes zoster, better known as zona or shingles, at a later age. Using mathematic modeling, James Wambua (Hasselt University) is therefore investigating whether it is advisable to vaccinate children in Belgium against this childhood disease.
Tim
Bomberna
FWO
UGent

Liver cancer: how do we get the medicines to the tumor?

As if developing a cancer drug is not difficult enough, you still have to successfully get that medicine to the tumor. Tim Bomberna (Ghent University) explains how computer simulations show us the way.
Sam
Vanherle
FWO
UHasselt

Is the key to MS therapy hidden in your body?

Immune cells serve to protect us. In multiple sclerosis, however, some immune cells just turn against the body and damage the nervous system. Sam Vanherle (Hasselt University) wants to detect these 'bad guys' in patients' blood and get them back on the right track. 💉
Assia
Tiane
FWO
UHasselt

Progressive MS: looking for the switch in our DNA in ons DNA

Did you know that there are already more than 15 medications for multiple sclerosis? Yet the more than 1 million progressive MS patients do not benefit from them, because these drugs only work in the early stages of the disease. Assia Tiane wants to help unravel the disease in order to improve the quality of life of progressive MS patients.
Benedith
Oben
UHasselt

Cracking the genetic code of blood cancer multiple myeloma

Cracking codes, it's a thing in escape rooms. But it is also what Bénedith Oben tries, albeit in the laboratory. In this way, she hopes to find the key to better understand the development of multiple myeloma, a common blood cancer.
Hanne
Leysen
FWO
UAntwerpen

Communication as a source of medication with fewer side effects

How come medications have long leaflets with a whole list of possible side effects? That is what Hanne Leysen investigates. She looks at how signals are transmitted in our body, zooming in on cellular communication.
Marjolein
Orije
UAntwerpen

Protecting newborns by vaccinating the mummy

Marjolein Orije investigates whether vaccinating pregnant women helps to provide their child with the necessary antibodies against childhood diseases, such as whooping cough. Her research shows that vaccinating the pregnant mother also helps to boost the child's immune system, even if it is born prematurely.
Laurie
Freire Boullosa
UAntwerpen

Does an old rheumatism pill help against cancer?

It is a relatively new and promising path in cancer research: the reuse of old, non-cancer drugs. In her PhD, Laurie Freire Boullosa focuses on an old rheumatism pill and examines whether it can be used as a weapon against cancer.
Laura
Dirkx
FWO
UAntwerpen

Playing hide and seek with parasites

Ever heard of a sand fly? If this small fly stings you, you can catch the serious, tropical disease Leishmaniasis. This disease is not easy to combat, because the parasites are masters at hiding in your body. Luckily Laura Dirkx (UAntwerp) has a trick up her sleeve to trace them
Eva
Claeys
FWO
UAntwerpen

What happens in your brain when you are depressed? 😞 🧠

What happens in your brain when you are depressed? That is what Eva Claeys tries to find out. As a researcher in biological psychiatry, she wants to better understand the 'biology of the depressive brain'.